Cargando…

Association between serum 25-hydroxyvitamin D and osteoarthritis: A national population-based analysis of NHANES 2001–2018

BACKGROUND: Previous studies have not provided a consensus on the effect of serum 25-hydroxyvitamin D [25(OH)D] on osteoarthritis (OA). We aimed to evaluate the association using a large, nationally representative sample. METHODS: The cross-sectional data were obtained from the 2001 to 2018 National...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Guoyu, Lin, Yuan, Dai, Hanhao, Xu, Jie, Liu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011108/
https://www.ncbi.nlm.nih.gov/pubmed/36925955
http://dx.doi.org/10.3389/fnut.2023.1016809
_version_ 1784906314551394304
author Yu, Guoyu
Lin, Yuan
Dai, Hanhao
Xu, Jie
Liu, Jun
author_facet Yu, Guoyu
Lin, Yuan
Dai, Hanhao
Xu, Jie
Liu, Jun
author_sort Yu, Guoyu
collection PubMed
description BACKGROUND: Previous studies have not provided a consensus on the effect of serum 25-hydroxyvitamin D [25(OH)D] on osteoarthritis (OA). We aimed to evaluate the association using a large, nationally representative sample. METHODS: The cross-sectional data were obtained from the 2001 to 2018 National Health and Nutrition Examination Survey (NHANES). Individuals aged ≥40 years who had information of serum 25(OH)D, self-report OA, and related covariates were included. Multivariable logistic regression analysis was employed to assess the association between serum 25(OH)D and osteoarthritis. RESULTS: Among the 21,334 participants included (weighted mean age, 56.9 years; 48.5% men), the proportion of participants with high serum 25(OH)D concentrations (≥100 nmol/L) increased significantly from 4.2% in 2001–2006 to 18.8% in 2013–2018. Higher serum 25(OH)D levels were associated with more osteoarthritis prevalence in fully adjusted model (odd ratio [OR] 1.25 [95% CI: 1.10, 1.43] for the 50–75 nmol/L group; OR 1.62 [95% CI: 1.42, 1.85] for the 75–100 nmol/L group; OR 1.91 [95% CI: 1.59, 2.30] for the ≥100 nmol/L group; with <50 nmol/L group as the reference) (p < 0.001 for trend). The association was consistent across several sensitivity analyses, including propensity score methods and excluding participants who had received vitamin D supplement. In subgroup analysis, the OR for the association increased significantly with body mass index (BMI) (BMI < 25 kg/m(2), 1.01 [95% CI: 1.04, 1.08]; BMI 25–30 kg/m(2), 1.05 [95% CI: 1.01, 1.08]; BMI ≥ 30 kg/m(2), 1.10 [95% CI: 1.06, 1.13]; p = 0.004 for interaction). CONCLUSION: There was a positive correlation between serum 25(OH)D and osteoarthritis with a possible modification by BMI. Our finding raises concerns about the potential adverse effects of high serum 25(OH)D on osteoarthritis, particularly among obese individuals. More well-designed studies are still needed to validate our findings in future.
format Online
Article
Text
id pubmed-10011108
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100111082023-03-15 Association between serum 25-hydroxyvitamin D and osteoarthritis: A national population-based analysis of NHANES 2001–2018 Yu, Guoyu Lin, Yuan Dai, Hanhao Xu, Jie Liu, Jun Front Nutr Nutrition BACKGROUND: Previous studies have not provided a consensus on the effect of serum 25-hydroxyvitamin D [25(OH)D] on osteoarthritis (OA). We aimed to evaluate the association using a large, nationally representative sample. METHODS: The cross-sectional data were obtained from the 2001 to 2018 National Health and Nutrition Examination Survey (NHANES). Individuals aged ≥40 years who had information of serum 25(OH)D, self-report OA, and related covariates were included. Multivariable logistic regression analysis was employed to assess the association between serum 25(OH)D and osteoarthritis. RESULTS: Among the 21,334 participants included (weighted mean age, 56.9 years; 48.5% men), the proportion of participants with high serum 25(OH)D concentrations (≥100 nmol/L) increased significantly from 4.2% in 2001–2006 to 18.8% in 2013–2018. Higher serum 25(OH)D levels were associated with more osteoarthritis prevalence in fully adjusted model (odd ratio [OR] 1.25 [95% CI: 1.10, 1.43] for the 50–75 nmol/L group; OR 1.62 [95% CI: 1.42, 1.85] for the 75–100 nmol/L group; OR 1.91 [95% CI: 1.59, 2.30] for the ≥100 nmol/L group; with <50 nmol/L group as the reference) (p < 0.001 for trend). The association was consistent across several sensitivity analyses, including propensity score methods and excluding participants who had received vitamin D supplement. In subgroup analysis, the OR for the association increased significantly with body mass index (BMI) (BMI < 25 kg/m(2), 1.01 [95% CI: 1.04, 1.08]; BMI 25–30 kg/m(2), 1.05 [95% CI: 1.01, 1.08]; BMI ≥ 30 kg/m(2), 1.10 [95% CI: 1.06, 1.13]; p = 0.004 for interaction). CONCLUSION: There was a positive correlation between serum 25(OH)D and osteoarthritis with a possible modification by BMI. Our finding raises concerns about the potential adverse effects of high serum 25(OH)D on osteoarthritis, particularly among obese individuals. More well-designed studies are still needed to validate our findings in future. Frontiers Media S.A. 2023-02-28 /pmc/articles/PMC10011108/ /pubmed/36925955 http://dx.doi.org/10.3389/fnut.2023.1016809 Text en Copyright © 2023 Yu, Lin, Dai, Xu and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Nutrition
Yu, Guoyu
Lin, Yuan
Dai, Hanhao
Xu, Jie
Liu, Jun
Association between serum 25-hydroxyvitamin D and osteoarthritis: A national population-based analysis of NHANES 2001–2018
title Association between serum 25-hydroxyvitamin D and osteoarthritis: A national population-based analysis of NHANES 2001–2018
title_full Association between serum 25-hydroxyvitamin D and osteoarthritis: A national population-based analysis of NHANES 2001–2018
title_fullStr Association between serum 25-hydroxyvitamin D and osteoarthritis: A national population-based analysis of NHANES 2001–2018
title_full_unstemmed Association between serum 25-hydroxyvitamin D and osteoarthritis: A national population-based analysis of NHANES 2001–2018
title_short Association between serum 25-hydroxyvitamin D and osteoarthritis: A national population-based analysis of NHANES 2001–2018
title_sort association between serum 25-hydroxyvitamin d and osteoarthritis: a national population-based analysis of nhanes 2001–2018
topic Nutrition
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011108/
https://www.ncbi.nlm.nih.gov/pubmed/36925955
http://dx.doi.org/10.3389/fnut.2023.1016809
work_keys_str_mv AT yuguoyu associationbetweenserum25hydroxyvitamindandosteoarthritisanationalpopulationbasedanalysisofnhanes20012018
AT linyuan associationbetweenserum25hydroxyvitamindandosteoarthritisanationalpopulationbasedanalysisofnhanes20012018
AT daihanhao associationbetweenserum25hydroxyvitamindandosteoarthritisanationalpopulationbasedanalysisofnhanes20012018
AT xujie associationbetweenserum25hydroxyvitamindandosteoarthritisanationalpopulationbasedanalysisofnhanes20012018
AT liujun associationbetweenserum25hydroxyvitamindandosteoarthritisanationalpopulationbasedanalysisofnhanes20012018